Chief Business Advisor
Rosemarie joined Sigmoid in late 2011 bringing more than 14 years’ experience in business development, strategy and project management. Most recently, from 2008 – 2011, Rosemarie was Senior Director, Corporate Development at Elan Corporation, plc, involved in a number of major corporate transactions. Prior to that, she held a number of roles in the drug delivery division of Elan, the corporate development group in New York and the launch team for Tysabri®. Rosemarie also worked as a management consultant with McKinsey & Company. Rosemarie is a Member of the Pharmaceutical Society of Ireland, completed her B.Sc. (Pharm) degree at Trinity College, Dublin, Ireland and her MBA at INSEAD, France.
SmPill® is the main focus of Sigmoid’s current development work and underpins all product development programmes. CyCol®, Sigmoid’s lead clinical development program, which is advancing into Phase 3 trials for moderate to severe ulcerative colitis, was uniquely enabled using SmPill® drug delivery technology.